Delay for Peanut Allergy Drug Sinks Biotech Stock

(Bloomberg) -- DBV Technologies SA lost two-thirds of its market value after it withdrew a U.S. application for a peanut allergy patch for children, shocking investors and prompting at least four a...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.